The DOI matches its Crossref record; 19 of the 23 references it cites were found in a registry or an index.
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
Abstract
BACKGROUND Multiple myeloma accounted for 176 404 (14%) of 1 278 362 the incidence cases leukaemia, lymphoma, and multiple myeloma in 2020. Identifying its geographical distribution, risk factors, and epidemiological trends could help identify high-risk population groups. We aimed to examine the worldwide incidence, mortality, associated risk factors, and temporal trends of multiple myeloma by sex, age, and geographical region. METHODS The incidence and mortality of multiple myeloma were extracted from Global Cancer Observatory (2020), Cancer Incidence in Five Continents, WHO mortality database, Nordic Cancer Registries, and Surveillance, Epidemiology, and End Results Program (1980-2019). The WHO Global Health Observatory data repository was searched for the age-standardised prevalence of lifestyle and metabolic risk factors (2010). Associations with risk factors were examined by multivariable regression. The temporal trends were evaluated by average annual percentage change (AAPC) using joinpoint regression. FINDINGS The age-standardised rate (ASR) of multiple myeloma incidence was 1·78 (95% UI 1·69-1·87) per 100 000 people globally and mortality was 1·14 (95% UI 1·07-1·21) per 100 000 people globally in 2020. Increased incidence and mortality were associated with higher human development index, gross domestics product, prevalence of physical inactivity, overweight, obesity, and diabetes. Australia and New Zealand (ASR 4·86 [4·66-5·07]), northern America (4·74 [4·69-4·79]),…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
(2005) · Europe PMC (PubMed Central) · Cited by 1,975
Mathers, C., Fat, D., Inoue, M., Rao, C., & Lopez, A. D. (2005) · Bulletin of the World Health Organization · doi:10.1590/s0042-96862005000300009 · Cited by 1,296
Estimating average annual per cent change in trend analysis
Clegg, L. X., Hankey, B. F., Tiwari, R., Feuer, E. J., & Edwards, B. K. (2009) · Statistics in Medicine · doi:10.1002/sim.3733 · Cited by 1,256
Multiple myeloma epidemiology and survival: A unique malignancy
Kazandjian, D. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.11.004 · Cited by 765
Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?
Shah, S. C., Kayamba, V., Peek, R. M., & Heimburger, D. (2019) · Journal of Global Oncology · doi:10.1200/jgo.18.00200 · Cited by 382
Environmental and Occupational Causes of Cancer: New Evidence 2005-2007
Clapp, R. W., Jacobs, M. M., & Loechler, E. L. (2008) · Reviews on Environmental Health · doi:10.1515/reveh.2008.23.1.1 · Cited by 371
Landgren, O., Gridley, G., Turesson, I., Caporaso, N. E., Goldin, L. R., Baris, D., Fears, T. R., Hoover, R. N., & Linet, M. S. (2006) · Blood · doi:10.1182/blood-2005-08-3449 · Cited by 333
Epidemiology, Staging, and Management of Multiple Myeloma
Padala, S. A., Barsouk, A., Barsouk, A., Rawla, P., Vakiti, A., Kolhe, R., Kota, V., & Ajebo, G. H. (2021) · Medical Sciences · doi:10.3390/medsci9010003 · Cited by 332
Epidemiological patterns of leukaemia in 184 countries: a population-based study
Miranda-Filho, A., Piñeros, M., Ferlay, J., Soerjomataram, I., Monnereau, A., & Bray, F. (2018) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30232-6 · Cited by 293
Research works printed but not linked: 1
- Nwabuko, 2019, Risk factors versus causal inferences: the implications on multiple myeloma in developed versus developing countries, Onkologia i Radioterapia, 13, 84
Cited by
Global burden of hematologic malignancies and evolution patterns over the past 30 years
Zhang, N., Wu, J., Wang, Q., Liang, Y., Li, X., Chen, G., Ma, L., Liu, X., & Zhou, F. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00853-3 · Cited by 432
“Only several local studies have reported the burden of individual diseases [4, 5].”
Malard, F., Neri, P., Bahlis, N. J., Terpos, E., Moukalled, N., Hungria, V. T. M., Manier, S., & Mohty, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00529-7 · Cited by 337
Dagar, G., Gupta, A., Masoodi, T., Nisar, S., Merhi, M., Hashem, S., Chauhan, R., Dagar, M., Mirza, S., Bagga, P., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04292-3 · Cited by 205
“Although multiple myeloma is rare cancer, it has been recently reported that its global incidence is rising [145].”
BackgroundThe global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045
da Costa, A. M., Laversanne, M., Marcos‐Gragera, R., Chaves, H. V. S., McShane, C. M., Bray, F., & Znaor, A. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae321 · Cited by 112
Huang, J., Chan, S. C., Ko, S., Lok, V., Zhang, L., Xu, L., Lucero‐Prisno, D. E., Xu, W., Zheng, Z., Elcarte, E. S., et al. (2023) · American Journal of Clinical Dermatology · doi:10.1007/s40257-023-00795-3 · Cited by 87
“Although HDI and GDP are correlated to some extent, they can have distinctly different implications on risk factors and cancer incidence and mortality [12, 13].”
BackgroundSelf-citation
Metadata
- Authors
- Huang, J., Chan, S. C., Lok, V., Zhang, L., Lucero-Prisno, D. E., Xu, W., Zheng, Z.-J., Elcarte, E., Withers, M., & Wong, M. C. S.
- Affiliations
- Chinese University of Hong Kong (HK)
- Karolinska University Hospital (SE)
- The University of Melbourne (AU)
- Fudan University (CN)
- Peking University (CN)
- University of the Philippines Manila (PH)
- University of Southern California (US)
- Corresponding author
- Wong, Martin C S
- ORCID
- Venue
- The Lancet Haematology
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 9
- Issue
- 9
- Pages
- e670-e677
- ISSN
- 2352-3026 (ISSN-L)
- OpenAlex
- W4285498552
- Semantic Scholar
- fb89781adfb04f725344da0f8891349496d6ab6c
- Cited by
- 229
- References
- 23
- Citations by year
- 2026: 51 · 2025: 84 · 2024: 57 · 2023: 32 · 2022: 4
- FWCI
- 32.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet Haematology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
- Keywords
- multiple myeloma, incidence, mortality, risk factors, temporal trends, geographic distribution, physical inactivity, obesity, diabetes mellitus, Human Development Index, economic development, sex differences, age-standardized rates, global cancer burden, cancer registry data, lifestyle risk factors, metabolic risk factors, cancer prevention policy, health equity, cancer screening and early detection, cancer survivorship
- MeSH terms
- Female, Humans, Male, Multiple Myeloma, Registries, Risk Factors, Global Health, Incidence, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. https://app.cochat.ai/papers/10.1016/s2352-3026(22)00165-x
- The paper
- Huang, J., Chan, S. C., Lok, V., Zhang, L., Lucero-Prisno, D. E., Xu, W., Zheng, Z.-J., Elcarte, E., Withers, M., & Wong, M. C. S. (2022). The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(22)00165-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.